Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1991-9-23
|
pubmed:abstractText |
We have studied growth, function, and phenotype of purified NK and T cells in long-term cultures and compared these parameters to those of conventionally prepared interleukin-2-activated lymphocytes with killer cell activity (LAK). Enrichment of NK and T cells was achieved by Percoll density gradient. Growth was analyzed by cell counts and [3H]TdR uptake. Cytotoxicity and tumor-binding efficacy were assessed in a 3-h 51Cr and single cell agarose assay, respectively, against K-562, Daudi, human ovarian cell line Ovcar-3, and fresh leukemic blasts. We found that long-term proliferation and lytic activity were highest in NK-enriched and lowest in T-enriched cultures. Conventional LAK cultures generated medium cytotoxicity levels. Lytic activity declined within 3 weeks in cultures not enriched for NK cells, while NK-enriched cultures showed high levels of cytotoxicity up to 6 weeks. No change was found in binding activity within 3 weeks with the exception of T cell-enriched fraction. A number of changes in the phenotypic patterns was observed in IL-2 cultures; the CD56+/CD3-/+ and CD56+/CD8+ subset increased in most cultures, whereas the CD56-/CD3+ subset decreased over time. The highly enriched NK cell culture maintained its NK cell phenotype over 5-6 weeks. We also delineated the most cytotoxic lymphocyte subset in long-term IL-2 cultures by complement dependent cytotoxic assays and fluorescence-activated cell sorting (FACS). Lytic activity in conventional LAK as well as in T and NK cell-enriched IL-2 cultures was mediated primarily by CD56+, CD16+, CD3- NK cells. The clinical implication of these studies is discussed.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1056-5477
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1651770-Cell Division,
pubmed-meshheading:1651770-Cell Membrane,
pubmed-meshheading:1651770-Cell Separation,
pubmed-meshheading:1651770-Cells, Cultured,
pubmed-meshheading:1651770-Cytotoxicity, Immunologic,
pubmed-meshheading:1651770-Flow Cytometry,
pubmed-meshheading:1651770-Humans,
pubmed-meshheading:1651770-Immunophenotyping,
pubmed-meshheading:1651770-Interleukin-2,
pubmed-meshheading:1651770-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:1651770-Killer Cells, Natural,
pubmed-meshheading:1651770-Leukocyte Count,
pubmed-meshheading:1651770-Lymphocyte Activation,
pubmed-meshheading:1651770-Povidone,
pubmed-meshheading:1651770-Silicon Dioxide,
pubmed-meshheading:1651770-T-Lymphocytes,
pubmed-meshheading:1651770-Time Factors
|
pubmed:year |
1991
|
pubmed:articleTitle |
Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.
|
pubmed:affiliation |
Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|